# reload+after+2024-01-21 12:26:44.609388
address1§4503 Glencoe Avenue
city§Marina del Rey
state§CA
zip§90292
country§United States
phone§858 829 0829
fax§310 665 2963
website§https://www.armatapharma.com
industry§Biotechnology
industryKey§biotechnology
industryDisp§Biotechnology
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
fullTimeEmployees§72
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Mina  Pastagia M.D., MS', 'age': 48, 'title': 'Chief Medical Officer', 'yearBorn': 1975, 'fiscalYear': 2022, 'totalPay': 537600, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Deborah L. Birx M.D.', 'age': 66, 'title': 'CEO & Director', 'yearBorn': 1957, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Richard  Rychlik', 'age': 67, 'title': 'VP, Corporate Controller & Principal Financial Officer', 'yearBorn': 1956, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Bryan  Kadotani', 'title': 'Vice President of Program Management & Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Pierre  Kyme Ph.D.', 'title': 'Vice President of Business & Corporate Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.704
priceToSalesTrailing12Months§27.743317
currency§USD
dateShortInterest§1702598400
forwardEps§-0.88
exchange§ASE
quoteType§EQUITY
shortName§Armata Pharmaceuticals, Inc.
longName§Armata Pharmaceuticals, Inc.
firstTradeDateEpochUtc§769440600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§e9006f47-0d3e-3b07-8861-14c121fcb2a4
messageBoardId§finmb_84546611
gmtOffSetMilliseconds§-18000000
targetHighPrice§9.0
targetLowPrice§7.0
targetMeanPrice§8.0
targetMedianPrice§8.0
recommendationMean§1.5
recommendationKey§strong_buy
numberOfAnalystOpinions§2
quickRatio§1.483
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
